Cargando…

Anti-Mullerian-hormone levels during pregnancy and postpartum

BACKGROUND: The number of unintentionally childless couples is increasing as more couples seek to conceive for the first time in the third or fourth decade of the woman’s life. Determination of ovarian reserve is an essential component of infertility assessment. The Anti-Müllerian-Hormone (AMH) seem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Köninger, Angela, Kauth, Alexis, Schmidt, Boerge, Schmidt, Markus, Yerlikaya, Guelen, Kasimir-Bauer, Sabine, Kimmig, Rainer, Birdir, Cahit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724719/ https://www.ncbi.nlm.nih.gov/pubmed/23844593 http://dx.doi.org/10.1186/1477-7827-11-60

Ejemplares similares

Afamin: an early predictor of preeclampsia
por: Köninger, Angela, et al.
Publicado: (2018)

Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay
por: Köninger, A., et al.
Publicado: (2015)

Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study
por: Köninger, Angela, et al.
Publicado: (2018)

Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
por: Köninger, Angela, et al.
Publicado: (2019)

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
por: Köninger, Angela, et al.
Publicado: (2014)

Course of the sFlt-1/PlGF ratio in fetal growth restriction and correlation with biometric measurements, feto-maternal Doppler parameters and time to delivery
por: Andrikos, A., et al.
Publicado: (2021)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
por: Keup, Corinna, et al.
Publicado: (2023)

Early Detection of Maternal Risk for Preeclampsia
por: Mikat, B., et al.
Publicado: (2012)

Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer Patients
por: Mach, Pawel, et al.
Publicado: (2021)

Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients
por: Keup, Corinna, et al.
Publicado: (2021)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2022)

Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients
por: Keup, Corinna, et al.
Publicado: (2019)

Cervical ectopic pregnancy – the first case of live birth and uterus-conserving management
por: Köninger, Angela, et al.
Publicado: (2023)

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2009)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients
por: Keup, Corinna, et al.
Publicado: (2020)

Clinical Utilities of Anti-Müllerian Hormone
por: Russell, Nicole, et al.
Publicado: (2022)

Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests
por: Johnson, Alexis, et al.
Publicado: (2023)

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
por: Kuhlmann, Jan Dominik, et al.
Publicado: (2012)

Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients
por: Bittner, Ann‐Kathrin, et al.
Publicado: (2020)

Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone
por: Ferguson, Jackie MC, et al.
Publicado: (2018)

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2009)

Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
por: Chebouti, Issam, et al.
Publicado: (2016)

Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer
por: Buderath, Paul, et al.
Publicado: (2016)

Decreased Anti-Müllerian hormone and Anti-Müllerian hormone receptor type 2 in hypothalami of old Japanese Black cows
por: KEREILWE, Onalenna, et al.
Publicado: (2020)

Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles
por: Wu, Cheng-Hsuan, et al.
Publicado: (2019)

Relationship Between Anti-Müllerian Hormone and In Vitro Fertilization-Embryo Transfer in Clinical Pregnancy
por: Sun, Xing Yu, et al.
Publicado: (2020)

Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study
por: McCredie, Sarah, et al.
Publicado: (2023)

Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors
por: Kim, Jang Heub, et al.
Publicado: (2014)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Anti-Mullerian Hormone: Usefulness in Clinical Practice
por: Buhling, Kai J., et al.
Publicado: (2013)

Clinical Utility of Anti-Mullerian Hormone in Pediatrics
por: Kanakatti Shankar, Roopa, et al.
Publicado: (2021)

The roles of anti-Müllerian hormone in breast cancer
por: Chen, Xuan, et al.
Publicado: (2023)

Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2016)

EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
por: Chebouti, Issam, et al.
Publicado: (2017)

Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
por: Buderath, Paul, et al.
Publicado: (2019)

Fetal subdural hematoma, sickle cell disease and storage pool disease: A case report
por: Iannaccone, Antonella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iqhm1bohqbklnd3mj3144q1hjc